We are live on ! Find out more
GSK icon

GSK
GSK

1,031 hedge funds and large institutions have $20.7B invested in GSK in 2026 Q1 according to their latest regulatory filings, with 141 funds opening new positions, 315 increasing their positions, 381 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 82

63% more call options, than puts

Call options by funds: $222M | Put options by funds: $137M

36% more funds holding in top 10

Funds holding in top 10: 11 → 15 (+4)

5% more capital invested

Capital invested by funds: $19.6B → $20.7B (+$1.03B)

4% more funds holding

Funds holding: 995 → 1,031 (+36)

1.11% less ownership

Funds ownership: 19.53% → 18.42% (-1.1%)

17% less repeat investments, than reductions

Existing positions increased: 315 | Existing positions reduced: 381

Holders
1,031
Holders Change
+36
Holders Change %
+3.62%
% of All Funds
12.69%
Holding in Top 10
15
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+36.36%
% of All Funds
0.18%
New
141
Increased
315
Reduced
381
Closed
82
Calls
$222M
Puts
$137M
Net Calls
+$85.7M
Net Calls Change
-$49.4M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$282M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$154M
3
Goldman Sachs
Goldman Sachs
New York
+$127M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$111M
5
BlackRock
BlackRock
New York
+$94.1M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$534M
2
JEST
JTC Employer Solutions Trustee
Jersey
-$292M
3
UBS Group
UBS Group
Switzerland
-$227M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$145M
5
Holocene Advisors
Holocene Advisors
New York
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
RF
976
Rossby Financial
Florida
$5.15K +$4.66K +86 +1,433%
OWP
977
ORG Wealth Partners
Texas
$5.08K +$4.99K +92 New
NWM
978
Nova Wealth Management
Florida
$4.98K – – –
CTWM
979
Cherry Tree Wealth Management
Minnesota
$4.97K -$17.3K -320 -78%
MCM
980
MV Capital Management
Maryland
$4.97K +$3.74K +69 +329%
MAM
981
Morse Asset Management
Connecticut
$4.97K -$3.25K -60 -40%
GWP
982
Gen-Wealth Partners
Michigan
$4.97K – – –
SC
983
Swan Capital
Florida
$4.91K -$10.8K -200 -69%
MWA
984
Medallion Wealth Advisors
Connecticut
$4.86K – – –
IAS
985
IMA Advisory Services
Colorado
$4.79K -$488 -9 -9%
LSA
986
Leonteq Securities AG
Switzerland
$4.75K -$15.8K -292 -77%
MFP
987
Meramec Financial Planners
Missouri
$4.59K – – –
PWMG
988
Prestige Wealth Management Group
New Jersey
$4.45K – – –
WA
989
Walsh & Associates
Florida
$4.42K – – –
1NWS
990
1 North Wealth Services
Maryland
$4.42K – – –
M
991
MOTCO
Texas
$4.42K – – –
PK
992
Pflug Koory
Nebraska
$4.42K – – –
TCM
993
TD Capital Management
Tennessee
$4.42K – – –
EWM
994
Evolution Wealth Management
Florida
$4.42K +$4.33K +80 New
PWM
995
Proathlete Wealth Management
Florida
$4.36K -$3.69K -68 -46%
WCM
996
Westend Capital Management
California
$3.97K -$163 -3 -4%
CC
997
Corsicana & Co
Texas
$3.87K – – –
SFS
998
Sunrise Financial Services
Washington
$3.75K – – –
TSMHT
999
Thurston Springer Miller Herd & Titak
Indiana
$3.31K – – –
GWM
1000
Gilpin Wealth Management
Colorado
$3.26K – – –
38 39
40
41 42

GSK Hedge Fund Activity: Q1 2026 in Review

1,031 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q1 2026, worth a combined $20.7B — up 5.2% from $19.6B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new GSK positions and 82 closed out — a net gain of 59 holders — while 315 added to existing stakes and 381 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $282M. The largest seller was Dodge & Cox, cutting an estimated $534M.

  • 1,031 institutional investors held GSK (GSK) as of Q1 2026, up from 995 in Q4 2025.
  • Funds reported $20.7B of GSK stock for Q1 2026, up 5.2% quarter-over-quarter.
  • 141 funds opened new GSK positions in Q1 2026 and 82 closed out, a net change of +59 holders.
  • The largest GSK buyer in Q1 2026 was Morgan Stanley, an estimated $282M added.
  • The largest GSK seller in Q1 2026 was Dodge & Cox, an estimated $534M sold.

Based on aggregated 13F filings for Q1 2026.